Arvaya Healthcare (BSE: ARVAYA) is loss-making over the last 12 months, so a P/E ratio does not apply. Its share price on 6 Nov 2026 was ₹111.00, 23% below its 52-week high. Sales grew 194% a year over 3 years. It is a small-cap company with a market cap of ₹576 Cr, ranked 3rd of 11 Medical Distribution companies by market cap; the shares rose 143% over the past year.
- ₹111.00
- ₹111.00
- ₹111.00
- ₹116.00
- 200
Health check
- ReturnsAhead
+143.1% over a year, better than 6 of 7 peers.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- GrowthUnder pressure
Sales +193.6% a year over 3 years, but loss-making now.
- ProfitabilityWeak
ROCE 1.4% vs peer median 9.4%.
- Balance sheetStretched
Piotroski 2 of 9.
- Red flags3 to check
Loss-making over the last twelve months.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹576 Cr
- Small cap
- P/E
- n/a
- Industry 36.7
- Price to book
- n/a
- Peers 1.26
- Dividend yield
- 0.00%
- ROE
- 2.2%
- Peers 8.0%
- ROCE
- 1.4%
- Peers 9.4%
- Debt to equity
- n/a
- EPS (TTM)
- −₹0.29
- OPM (TTM)
- 0.0%
- Net margin 0.0%
- Sales growth
- n/a
- Year-ago quarter not reported
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- 75.94
Strengths and risks
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at 2.2%.
- Interest coverage of only 2.6×.
About Arvaya Healthcare
Arvaya Healthcare Limited provides spanning hospitals, pharmaceuticals, diagnostics, medical devices, telemedicine, medical tourism, health insurance and health technology. The company operates a multi-specialty hospital network under the SeCURE Hospitals brand across the Indian states of Karnataka and Maharashtra, offering in-patient, out-patient, surgical, and ancillary services across hospitals. The company offers MyArvaya, a patient-facing digital…
- Headquarters
- Guwahati
- Sector
- Healthcare
- ISIN
- INE491D01017
- Website
- arvayahealth.com
Price range
- Avg volume (3M)
- 526
- 1-year return
- plus 143.1%
- From 52-week high
- minus 23.4%
Peers · Medical Distribution
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENTEROEntero Healthcare Solutions | 1,900.40 | plus 8.34% | 8,279 | 66.0 | 4.90 | 11.3% | 6.7% | 4.4% | 25.7% | – | 0.00% | plus 62.4% |
| APPLAptus Pharma | 465.00 | plus 0.92% | 797 | 100.2 | 28.06 | 29.3% | 31.7% | 15.4% | 49.6% | 187.5% | 0.00% | plus 772.6% |
| ARVAYAArvaya Healthcare | 111.00 | minus 4.31% | 576 | – | – | 1.4% | 2.2% | 0.0% | 193.6% | – | 0.00% | plus 143.1% |
| EVEXIAEvexia Lifecare | 1.46 | minus 3.31% | 274 | 146.0 | 0.67 | 0.3% | 0.3% | 1.6% | 16.6% | 34.5% | 0.00% | minus 15.2% |
| NOVELIXNovelix Pharmaceuticals | 64.66 | minus 4.91% | 184 | 36.7 | 2.93 | 7.4% | 8.0% | 3.1% | 354.8% | – | 0.00% | plus 29.5% |
| AMWILLAmwill Health Care | 44.00 | plus 5.67% | 88 | 7.8 | 1.06 | 15.5% | 14.4% | 14.1% | 14.7% | 54.2% | 2.27% | minus 25.4% |
| CBPLChandra Bhagat Pharma | 55.50 | minus 4.31% | 42 | 13.7 | 1.26 | – | 9.7% | 2.5% | – | – | 0.00% | plus 45.0% |
| WELCUREWelcure Drugs and Pharmaceuticals | 0.18 | minus 5.26% | 22 | – | 0.23 | −5.7% | −5.5% | −1.5% | – | – | 0.00% | minus 62.7% |
| Median of 7 peers | – | −3.31% | 184 | 51.4 | 1.26 | 9.4% | 8.0% | 3.1% | 25.7% | 54.2% | 0.00% | 29.5% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| – | – | – | 9.1 | 29.9 | |
| – | – | – | 7.7 | 25.9 | |
| −0.3 | −0.3 | −0.2 | 1.4 | 4 | |
| – | – | – | 15.2% | 13.3% | |
| 0 | 0 | 0 | 1.3 | 0.2 | |
| – | 0 | 0 | 0.4 | 1.4 | |
| – | – | – | 0.6 | 2.2 | |
| −0.3 | −0.3 | −0.2 | 1.7 | 0.6 | |
| – | – | – | 11.5% | 4.9% | |
| −0.3 | −0.3 | −0.2 | 1.3 | 0.4 | |
| -0.53 | -0.41 | -0.22 | 0.26 | 0.08 |
Profit & loss
- Sales CAGR 3Y
- +193.6%
- ROE
- 2.2%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 0.3 | 0.3 | 0.3 | 7.6 | |
| – | minus 6.6% | minus 1.6% | +2655.2% | |
| 0.6 | 0.6 | 0.8 | 6.6 | |
| −0.3 | −0.4 | −0.5 | 1 | |
| −107.3% | −130.6% | −180.9% | 13.6% | |
| 0.1 | 0.3 | 0.2 | 1.4 | |
| 0 | 0 | 0 | 0.4 | |
| 0.1 | 0 | 0 | 0.6 | |
| −0.2 | – | 0.6 | −0.3 | |
| −0.4 | −0.1 | 0.2 | 1.1 | |
| 0.1% | −0.5% | 28.7% | 17.4% | |
| −0.4 | −0.1 | 0.1 | 0.7 | |
| -1.48 | -0.39 | 0.45 | 0.69 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 3 | 3 | 3 | 48 | |
| 0.5 | 0.4 | 0.5 | 11.9 | |
| 0.1 | 0.1 | – | 49.4 | |
| 0 | 0 | 0.1 | 31.3 | |
| 3.6 | 3.5 | 3.6 | 141 | |
| 0.8 | 0.4 | – | 64.7 | |
| – | – | – | 2.1 | |
| 0.2 | 0.4 | 0.6 | 0.4 | |
| 1.6 | 1.6 | 2.7 | 2.4 | |
| 1 | 1.1 | 0.3 | 71 | |
| 3.6 | 3.5 | 3.6 | 141 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −0.3 | −0.3 | 0.2 | −3.3 | |
| −0.1 | 0.3 | 0.9 | −5.6 | |
| 0.1 | −0 | −0.1 | 8.5 | |
| −0.3 | 0 | 1.1 | −0.4 | |
| −0.1 | −0 | – | −4.7 | |
| −0.4 | −0.3 | 0.2 | −7.9 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.